#1 Clinical Trials Search in Europe

Cannabidiol

Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, has gained significant attention in medical research for its potential therapeutic properties. This article examines various clinical trials investigating the use of CBD in treating different conditions, from epilepsy to COVID-19. These studies aim to understand CBD’s efficacy, safety profile, and potential applications in improving patient outcomes across various medical fields.

Table of Contents

What is Cannabidiol (CBD)?

Cannabidiol, commonly known as CBD, is a natural compound found in the cannabis plant. Unlike its more famous cousin THC (tetrahydrocannabinol), CBD does not cause a “high” or psychoactive effects. CBD is being studied for its potential therapeutic benefits in various medical conditions[1].

CBD is available in different forms, including:

  • Oral solutions (e.g., Epidiolex, Epidyolex): These are liquid forms of CBD that can be taken by mouth[2].
  • Capsules or tablets: CBD in pill form for easy dosing[3].
  • Buccal strips: These are thin strips that dissolve when placed between the cheek and gum[4].

Medical Conditions Treated with CBD

Research is ongoing to determine the effectiveness of CBD in treating various medical conditions. Some of the conditions being studied include:

  • Epilepsy: CBD (Epidiolex) is FDA-approved for treating certain types of severe epilepsy, including Lennox-Gastaut syndrome, Dravet syndrome, and seizures associated with tuberous sclerosis complex[2].
  • COVID-19: Researchers are investigating whether CBD can help reduce inflammation and improve outcomes in patients with severe COVID-19[1].
  • Hereditary Epidermolysis Bullosa: This is a rare genetic skin condition causing severe blistering. CBD is being studied for its potential to reduce itching (pruritus) in children with this condition[5].
  • Sturge-Weber Syndrome: This is a rare neurological disorder. CBD is being investigated for its potential to improve cognitive function, mood, and behavior in patients with this condition[6].
  • Obsessive-Compulsive Disorder (OCD) and Related Disorders: Researchers are exploring whether CBD can help reduce symptoms of OCD, trichotillomania (hair-pulling disorder), skin picking, Tourette’s syndrome, and hoarding disorder[7].
  • Pain Management: CBD is being studied for its potential to reduce pain and inflammation after bone fractures and other traumatic injuries[8].
  • Sanfilippo Syndrome: This is a rare genetic disorder affecting brain function. CBD is being investigated for its potential to improve behavior and overall function in patients with this condition[9].

How CBD Works

CBD interacts with the body’s endocannabinoid system, which plays a role in regulating various functions such as pain, mood, and inflammation. Some of the ways CBD may work include:

  • Reducing inflammation by inhibiting the release of pro-inflammatory substances[1].
  • Modulating the immune system response[1].
  • Interacting with receptors in the nervous system that affect pain perception[5].
  • Influencing neurotransmitter systems in the brain that regulate mood and behavior[6].

How CBD is Administered

The way CBD is given depends on the condition being treated and the specific study or product. Some common methods include:

  • Oral solutions: Taken by mouth, often twice daily with meals[2].
  • Capsules or tablets: Swallowed with water, typically once or twice daily[3].
  • Buccal strips: Placed between the cheek and gum to dissolve[4].

Dosages can vary widely depending on the condition and individual factors. Always follow your healthcare provider’s instructions or the specific study protocol for dosing.

Potential Side Effects

While CBD is generally considered to have a good safety profile, it can cause some side effects. Common side effects may include:

  • Drowsiness or fatigue
  • Decreased appetite
  • Diarrhea
  • Changes in weight
  • Potential interactions with other medications

In some studies, researchers are specifically monitoring for potential effects on liver function[2]. It’s important to discuss any CBD use with your healthcare provider, especially if you’re taking other medications.

Ongoing Research

Many clinical trials are currently underway to better understand the effects, safety, and optimal use of CBD for various conditions. Some areas of ongoing research include:

  • Long-term safety and potential for liver injury with prolonged use[2].
  • Effects of CBD during pregnancy and on infant development[10].
  • Optimal dosing and administration methods for different conditions[4].
  • Potential interactions with other medications, including opioids for pain management[8].

As research continues, our understanding of CBD’s potential benefits and risks will likely evolve. Always consult with a healthcare professional before starting any new treatment, including CBD.

Study Focus Key Findings/Objectives Patient Population CBD Administration
Pharmacokinetics Evaluating bioavailability of CBD under different conditions Healthy individuals Oral capsules, varying doses
Liver Safety Assessing potential for chronic liver injury Patients with epilepsy syndromes Oral solution, long-term use
Pregnancy Outcomes Evaluating safety during pregnancy Pregnant women exposed to Epidiolex Epidiolex exposure during pregnancy
Sanfilippo Syndrome Exploring efficacy in neurobehavioral symptoms Patients with Sanfilippo syndrome Oral Epidiolex, dose escalation
Sturge-Weber Syndrome Investigating cognitive improvements Patients with Sturge-Weber syndrome Oral CBD solution
Pain Management Assessing pain relief after orthopaedic trauma Patients with long bone fractures Oral tablets, two dose levels
COVID-19 Treatment Exploring anti-inflammatory effects in severe cases Patients with severe COVID-19 Oral CBD solution

FAQ

  • What is Cannabidiol (CBD)? Cannabidiol (CBD) is a non-psychoactive compound derived from the cannabis plant. It has gained attention for its potential therapeutic properties without causing the 'high' associated with marijuana use.
  • What medical conditions are being studied with CBD in clinical trials? Clinical trials are exploring CBD's potential in treating various conditions, including epilepsy, pain management after trauma, obsessive-compulsive disorders, Sturge-Weber syndrome, Sanfilippo syndrome, and even severe COVID-19 infections.
  • Is CBD safe to use? CBD generally has a good safety profile, but like any medication, it can have side effects. Common side effects may include fatigue, changes in appetite, and diarrhea. Clinical trials are ongoing to further evaluate its safety in different patient populations.
  • How is CBD administered in these clinical trials? CBD is administered in various forms depending on the study, including oral solutions, capsules, tablets, and even buccal (cheek) strips. The dosage and frequency vary based on the condition being treated and the specific trial protocol.
  • Can CBD interact with other medications? Yes, CBD can interact with other medications. It's important for patients to inform their healthcare providers about all medications they're taking, including CBD, to avoid potential drug interactions. Some trials are specifically studying these interactions, such as with opioids in pain management.

Ongoing Clinical Trials on Cannabidiol

  • Study on the Effect of Cannabidiol (CBD) on Sleep Quality in Multiple Sclerosis Patients with Insomnia

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder

    Not recruiting

    2 1
    Investigated drugs:
    France

  • Study on Cannabidiol and Aripiprazole for Treating Substance-Induced Psychosis in Young Patients

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Improving Quality of Life in Cancer Patients Using Dronabinol and Cannabidiol

    Not recruiting

    2 1
    Investigated drugs:
    Germany

  • Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Ireland

  • Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Ireland

  • Study on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on the Effect of Cannabidiol (CardiolRx) on Heart Recovery in Patients with Acute Myocarditis

    Not recruiting

    2 1 1
    Investigated drugs:
    France

  • Study on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

  • Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Cannabidiol (CBD): A non-psychoactive compound derived from cannabis plants, being studied for various therapeutic applications.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Bioavailability: The proportion of a drug or substance that enters the circulation when introduced into the body and is able to have an active effect.
  • Visual Analog Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, often used for pain assessment.
  • Cytokines: Small proteins important in cell signaling, particularly in immune responses and inflammation.
  • Acute Respiratory Distress Syndrome (ARDS): A serious lung condition causing fluid to build up in the air sacs, leading to breathing difficulties.
  • Sturge-Weber Syndrome: A rare neurological disorder characterized by a facial birthmark and neurological abnormalities.
  • Sanfilippo Syndrome: A rare genetic lysosomal storage disease causing progressive neurodegeneration.
  • Obsessive-Compulsive Disorder (OCD): A mental health condition characterized by persistent, intrusive thoughts and repetitive behaviors.
  • Epidiolex: A pharmaceutical-grade CBD oral solution approved for certain types of epilepsy.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being tested.
  • Double-blind study: A study design where neither the participants nor the researchers know who is receiving the actual treatment versus a placebo.
  • C-reactive protein (CRP): A blood test marker for inflammation in the body.
  • Ferritin: A blood protein that contains iron and is used as a marker for iron storage in the body.
  • Interleukin-6 (IL-6): A protein involved in immune responses and inflammation.

References

  1. https://clinicaltrials.gov/study/NCT04731116
  2. https://clinicaltrials.gov/study/NCT05044819
  3. https://clinicaltrials.gov/study/NCT05023070
  4. https://clinicaltrials.gov/study/NCT06574100
  5. https://clinicaltrials.gov/study/NCT05651607
  6. https://clinicaltrials.gov/study/NCT04447846
  7. https://clinicaltrials.gov/study/NCT04978428
  8. https://clinicaltrials.gov/study/NCT06448923
  9. https://clinicaltrials.gov/study/NCT06333041
  10. https://clinicaltrials.gov/study/NCT06113237